Dare Bioscience Inc (NASDAQ:DARE)
| 1.01 Delayed Data As of Mar 24 |  -0.01 / -0.98%Today’s Change | 0.82 Today|||52-Week Range 1.88 | +21.69% Year-to-Date |
Latest DARE News | Press Releases
No recent news for Dare Bioscience Inc.
Today’s Trading
| Previous close | 1.02 |
| Today’s open | 1.02 |
| Day’s range | 1.01 - 1.02 |
| Volume | 1,316 |
| Average volume (3 months) | 289,864 |
| Market cap | $86.5M |
Data as of 2:28pm ET, 03/24/2023
Growth & Valuation
| Earnings growth (last year) | +30.52% |
| Earnings growth (this year) | +49.74% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.21 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MTNBMatinas BioPharma Ho... | -0.01 | -2.57% |
| FBIOFortress Biotech Inc | -0.00 | -0.19% |
| ORMPOramed Pharmaceutica... | -0.02 | -0.92% |
| ACHVAchieve Life Science... | +0.24 | +5.10% |
Data as of 4:00pm ET, 03/24/2023
Financials
| Next reporting date | March 31, 2023 |
| EPS forecast (this quarter) | -$0.14 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$38.7M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
